APA (7th ed.) Citation

Kulikov, A. Y., Serpik, V. G., & Lila, A. M. Pharmacoeconomic rationale for switching patients with rheumatic diseases from original biologic disease-modifying antirheumatic drugs to biosimilars in context of the Russian healthcare system. IMA-PRESS LLC.

Chicago Style (17th ed.) Citation

Kulikov, A. Yu, V. G. Serpik, and A. M. Lila. Pharmacoeconomic Rationale for Switching Patients with Rheumatic Diseases from Original Biologic Disease-modifying Antirheumatic Drugs to Biosimilars in Context of the Russian Healthcare System. IMA-PRESS LLC.

MLA (9th ed.) Citation

Kulikov, A. Yu, et al. Pharmacoeconomic Rationale for Switching Patients with Rheumatic Diseases from Original Biologic Disease-modifying Antirheumatic Drugs to Biosimilars in Context of the Russian Healthcare System. IMA-PRESS LLC.